Both of Centurion Corporation's joint chairmen have kept adding shares in a company they already control, and the latest round of purchases was filed in mid-October 2026.

Han Seng Juan is reported to have added 608,300 shares at an average of about S$1.26, worth S$765,325, between 15 and 20 October, while David Loh Kim Kang added 200,000 shares at S$1.2483 on 20 October.

Han alone made seven purchases through 2025. Below, I go through the purchase history, what the 1H26 results say about the business they are backing, and what I think the signal is actually worth.

Centurion Corporation Limited is listed on the SGX under the code OU8, and its SGXNet notices carry the ISIN SG2D51973063.

Two people show up in the director dealing filings: Han Seng Juan, a non-executive director and joint chairman, and David Loh Kim Kang, an executive director and joint chairman. Both are also substantial shareholders.

In plain terms, these are not minority holders topping up a small position. They are the people who already sit on more than half the register.

It looks like a pattern. The Edge Singapore reported that Han made seven purchases in 2025, and the October 2026 trades extend the run.

Adding up the seven 2025 purchases gives about 1.82 million shares for roughly S$2.19 million, an average near S$1.20 (my own arithmetic from the reported prices). The October 2026 average of about S$1.26 is around 5% higher. That is the detail I find most interesting: the chairman has been willing to pay more, not wait for a dip.

Loh has been active too. The Edge Singapore reported that he added 100,000 shares at S$1.19 on 27 March 2025, and 10 million shares at 93.5 cents on 15 January 2025.

Think of Centurion as a landlord that rents beds rather than flats. As at 30 June 2026, its portfolio was about 85,528 beds, and most of them house foreign workers.

In plain terms, about 94 of every 100 beds are worker dormitory beds. So the insider purchases are really a view on dormitory demand in Singapore and Malaysia.

Revenue grew strongly, but the profit lines tell different stories depending on which one you read.

The honest crux is the bolded row. Revenue and core profit before minorities rose, yet profit attributable to Centurion's own shareholders fell, which Phillip Securities attributed to higher profits going to non-controlling interests.

Occupancy also eased: worker accommodation was 84% against 90%, with Singapore at 94% against 99% and Malaysia at 73% against 83%, as new beds ramp up. Management guided 2H26 revenue at about S$190 million, around 22% higher year on year.

The 3Q update on 11 November was reported with revenue up 41% to S$95.2 million.

Discover 7 Moat Stocks with deep competitive advantages, built to hold for the long haul. All explained in plain English for everyday investors.

A third-party roundup of Singapore director dealings in mid to late October 2026 named ten purchases. Here are the largest, alongside Centurion's two.

Han's purchase was the largest of the named trades in that roundup. Size alone proves nothing, but it does show this was real money rather than a token top-up.

Personally, I read it as a mild positive, with a big caveat.

The positive: the buyers are paying real money, repeatedly, and at higher prices than before. Owners who already hold most of the company are not adding for show.

The caveat: the signal is weaker than it looks. When insiders already control more than half the register, further purchases also tighten that control, and a Form 1 filing does not tell us why they bought. The two chairmen's deemed interests are reported separately, and I have not tried to add them together, as they may overlap.

For context, Phillip Securities set a sum-of-the-parts target of S$1.94 on 21 August 2026.

What I would watch: whether Singapore occupancy (94%) and Malaysia occupancy (73%) recover as new beds fill, whether profit to shareholders catches up with revenue growth, and whether the chairmen keep adding if the price keeps rising.

What I would watch next is the full-year result and whether the dealing pattern continues.

The SGX code is OU8, and the ISIN shown on its SGXNet notices is SG2D51973063.

Han Seng Juan, a non-executive director, and David Loh Kim Kang, an executive director. Both are also substantial shareholders.

A third-party roundup reported 608,300 shares by Han (about S$765,325) and 200,000 shares by Loh at S$1.2483.

It is a useful clue, not a forecast. It tells you what the people closest to the business did with their own money, but not why, and not whether they are right.

On SGXNet, under announcements titled Disclosure of Interest or Notification of Change in Interest by Director. The detail sits in the attached Form 1.

For 1H26 it declared an interim dividend of 2.0 cents per share, unchanged from 1H25. For other income ideas, see my guide to best SGX dividend stocks in 2026.

I have not confirmed Centurion's CPFIS eligibility, so check the CPF Board's list before you act. For SRS, check with your SRS operator bank and your broker.

It depends on the board lot size, which I have not verified for this counter. SGX has been cutting lot sizes on some stocks, so check your broker. My note on the SGX board lot change explains the background.

Set up SGXNet alerts for the counters you follow, or use a screener. My look at the Simply Wall St dividend tracker covers one such tool.

What this gives you is a clear example of insiders backing their own business repeatedly, with real money, and at rising prices. Han alone has made eight reported purchases across 2025 and October 2026.

The open question is how much to read into it. The chairmen already own most of the company, the filings do not explain their reasons, and 1H26 profit to shareholders fell even as revenue rose.

What I would do is read the SGXNet Form 1 filings yourself, then watch the full-year results for occupancy and shareholder profit before drawing a conclusion.

Join our community for more insights:
https://investkaki.com/community